Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

(RTTNews) - Specialty pharmaceutical company Collegium Pharmaceutical, Inc. (COLL) announced Monday it has entered into an authorized generic agreement with Hikma Pharmaceuticals USA Inc., pursuant to which Hikma will have the exclusive right to sell the authorized generic versio https://www.nasdaq.com/articles/collegium-pharma-partners-with-hikma-for-authorized-generics-of-nucynta-in-us